In the US, CoreWeave has signed leasing deals with the likes of Lincoln Rackhouse, Chirisa, Flexential, TierPoint, Digital ...

On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...

Germany’s Bayer has entered into an exclusive licensing agreement with privately-held Dewpoint Therapeutics for a heart ...

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck ...

Under the terms of the deal, MSD (known as Merck & Co in the US and Canada) is paying $30 million upfront for Modifi with up ...

CoreWeave’s commitment to invest over a billion dollars at the NEST campus demonstrates New Jersey’s leading role in ...

Modifi Biosciences, Inc., a leader in the development of direct DNA modification enabled cancer therapeutics, has been ...

In a report released today, Charlie CY Yang from Bank of America Securities maintained a Buy rating on Merck & Company (MRK – ...

After the disastrous performance of 2022, the market has recovered better than expected and is on a growth trajectory.

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

Shortly after Bicara Therapeutics raised more than $360 million in an IPO, the cancer biotech and its former parent company ...

Bernstein has recently initiated Merck & Co Inc (MRK) stock to Mkt Perform rating, as announced on October 17, 2024, according to Finviz. Earlier, on March 11, 2024, Societe Generale had reduced the ...